switching from dulaglutide to semaglutide What is the recommended dosing strategy when a patient Trulicity (dulaglutide) 2mg weekly oral tablet? Switching Between Glucagon-Like Peptide-1 Receptor

This may include a lower maintenance dose, lifestyle modifications, or transitioning off medication with a plan to support long-term success

Form-Specific Handling Requirements Handling requirements may vary based on the product type

One of the innovative treatments we offer is Ozempic, known generically as Semaglutide GLP-1 , which is primarily approved for managing type 2 diabetes

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for three primary indications: type 2 diabetes mellitus, chronic weight management, and cardiovascular risk reduction in adults with obesity/overweight and established cardiovascular disease

A 2025 University of British Columbia study found that women taking semaglutide had more than double the risk of hair loss compared to women on alternative weight loss medication